CLEARSIDE BIOMEDICAL INC's ticker is and the CUSIP is 185063954. A total of 3 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,784 | -22.3% | 5,500 | 0.0% | 0.00% | – |
| Q2 2023 | $6,160 | +18.5% | 5,500 | +10.0% | 0.00% | – |
| Q1 2023 | $5,200 | -7.1% | 5,000 | 0.0% | 0.00% | – |
| Q4 2022 | $5,600 | -49.1% | 5,000 | -50.0% | 0.00% | – |
| Q3 2022 | $11,000 | -75.0% | 10,000 | -66.7% | 0.00% | – |
| Q2 2022 | $44,000 | -40.5% | 30,000 | -6.5% | 0.00% | – |
| Q1 2022 | $74,000 | -70.6% | 32,100 | -64.9% | 0.00% | – |
| Q4 2021 | $252,000 | -41.4% | 91,500 | +27.8% | 0.00% | – |
| Q3 2021 | $430,000 | +84.5% | 71,600 | +49.8% | 0.00% | – |
| Q2 2021 | $233,000 | +651.6% | 47,800 | +276.4% | 0.00% | – |
| Q1 2021 | $31,000 | -97.5% | 12,700 | -98.0% | 0.00% | -100.0% |
| Q2 2020 | $1,223,000 | +8.9% | 650,700 | -1.5% | 0.01% | -33.3% |
| Q1 2020 | $1,123,000 | -14.7% | 660,700 | +45.6% | 0.01% | 0.0% |
| Q4 2019 | $1,316,000 | +1270.8% | 453,900 | +359.4% | 0.01% | +800.0% |
| Q2 2019 | $96,000 | -29.4% | 98,800 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $136,000 | +177.6% | 98,800 | +1135.0% | 0.00% | – |
| Q3 2018 | $49,000 | -90.1% | 8,000 | -82.7% | 0.00% | -100.0% |
| Q2 2018 | $495,000 | +432.3% | 46,300 | +432.2% | 0.00% | +300.0% |
| Q1 2018 | $93,000 | – | 8,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 30,000 | $44,000 | 0.00% |
| SIMPLEX TRADING, LLC | 37,800 | $55,000 | 0.00% |